See the Complete Picture.
Published loading...Updated

PLATEXLYMPH, a collaborative platform for exploring models of cells of patients with lymphoid hemopathies. - Centre de Recherches en Cancerologie de Toulouse

Summary by CRCT - Centre De Recherches en Cancérologie De Toulouse
PLATEXLYMPH, a collaborative platform for the exploration of models of cells of patients with lymphoid haemopathies. The NOLYMIT team led by Camille Laurent has been awarded a grant by the Carnot CALYM Institute, under the "Carnot device", managed by the National Research Agency (NRA) for the development of the PLATEXLYMPH (Collaborative platform for the exploration of models of cells of patients with lymphoid haemopathies). This program brings …
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right

PLATEXLYMPH, a collaborative platform for the exploration of models of cells of patients with lymphoid haemopathies. The NOLYMIT team led by Camille Laurent has been awarded a grant by the Carnot CALYM Institute, under the "Carnot device", managed by the National Research Agency (NRA) for the development of the PLATEXLYMPH (Collaborative platform for the exploration of models of cells of patients with lymphoid haemopathies). This program brings …

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

CRCT - Centre de Recherches en Cancérologie de Toulouse broke the news in on Tuesday, April 15, 2025.
Sources are mostly out of (0)